Terms: = Uterine cancer AND ERBB3, c-erbB3, 2065, P21860, p180-ErbB3, c-erbB-3, ErbB-3, MDA-BF-1, HER3, p85-sErbB3, MGC88033, p45-sErbB3, ENSG00000065361, erbB3-S AND Prognosis
12 results:
1. Clinicopathological and molecular analyses of uterine carcinosarcomas using next-generation sequencing: A single-center experience.
Erdogan EG; Yalta TD; Can N; Süt N; Taştekin E; Usta U; Puyan FÖ; Usturalı Keskin FE; Kurt BB
Indian J Pathol Microbiol; 2023; 66(3):449-455. PubMed ID: 37530323
[TBL] [Abstract] [Full Text] [Related]
2. Single-cell dissection of cellular and molecular features underlying human cervical squamous cell carcinoma initiation and progression.
Liu C; Zhang M; Yan X; Ni Y; Gong Y; Wang C; Zhang X; Wan L; Yang H; Ge C; Li Y; Zou W; Huang R; Li X; Sun B; Liu B; Yue J; Yu J
Sci Adv; 2023 Jan; 9(4):eadd8977. PubMed ID: 36706185
[TBL] [Abstract] [Full Text] [Related]
3. [Clinical study of hysteroscopical electroresection of FIGO type 3 myoma].
Chen LM; Zhang HW; Xie Y; Wang Q; Sui L
Zhonghua Fu Chan Ke Za Zhi; 2022 Oct; 57(10):746-752. PubMed ID: 36299177
[No Abstract] [Full Text] [Related]
4. erbb3 methylation and immune infiltration in tumor microenvironment of cervical cancer.
Yang X; Chen Y; Li M; Zhu W
Sci Rep; 2022 May; 12(1):8112. PubMed ID: 35581263
[TBL] [Abstract] [Full Text] [Related]
5. A pan-HER-targeted approach for recurrent or late-stage cervical cancer therapy: mechanisms, recent advances, and clinical prospects.
Liu Y; An Q; Zhao X
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4123-4131. PubMed ID: 32373948
[TBL] [Abstract] [Full Text] [Related]
6. Significance of Ebp1 and p53 protein expression in cervical cancer.
Liu L; Li XD; Chen HY; Cui JS; Xu DY
Genet Mol Res; 2015 Oct; 14(4):11860-6. PubMed ID: 26436510
[TBL] [Abstract] [Full Text] [Related]
7. Expression of the epidermal growth factor system in endometrial cancer.
Adonakis G; Androutsopoulos G; Koumoundourou D; Liava A; Ravazoula P; Kourounis G
Eur J Gynaecol Oncol; 2008; 29(5):450-4. PubMed ID: 19051810
[TBL] [Abstract] [Full Text] [Related]
8. The prognostic significance of human epidermal growth factor receptor correlations in squamous cell cervical carcinoma.
Fuchs I; Vorsteher N; Bühler H; Evers K; Sehouli J; Schaller G; Kümmel S
Anticancer Res; 2007; 27(2):959-63. PubMed ID: 17465227
[TBL] [Abstract] [Full Text] [Related]
9. Expression of the epidermal growth factor system in endometrioid endometrial cancer.
Ejskjaer K; Sørensen BS; Poulsen SS; Forman A; Nexø E; Mogensen O
Gynecol Oncol; 2007 Jan; 104(1):158-67. PubMed ID: 16962163
[TBL] [Abstract] [Full Text] [Related]
10. Chromosomal amplifications, 3q gain and deletions of 2q33-q37 are the frequent genetic changes in cervical carcinoma.
Rao PH; Arias-Pulido H; Lu XY; Harris CP; Vargas H; Zhang FF; Narayan G; Schneider A; Terry MB; Murty VV
BMC Cancer; 2004 Feb; 4():5. PubMed ID: 15018632
[TBL] [Abstract] [Full Text] [Related]
11. [The c-erbB-related oncoproteins in normal placenta and in gestational trophoblastic diseases (in vitro study)].
Fülöp V; Végh G; Doszpod J
Orv Hetil; 2001 Jun; 142(22):1147-54. PubMed ID: 11424588
[TBL] [Abstract] [Full Text] [Related]
12. Overexpression of p53, EGFR, c-erbB2 and c-erbb3 in endometrioid carcinoma of the ovary.
Leng J; Lang J; Shen K; Guo L
Chin Med Sci J; 1997 Jun; 12(2):67-70. PubMed ID: 11324501
[TBL] [Abstract] [Full Text] [Related]
